Literature DB >> 9338417

Effect of exercise intensity on skeletal muscle malonyl-CoA and acetyl-CoA carboxylase.

B B Rasmussen1, W W Winder.   

Abstract

Malonyl-CoA is synthesized by acetyl-CoA carboxylase (ACC) and is an inhibitor of fatty acid oxidation. Exercise induces a decline in skeletal muscle malonyl-CoA, which is accompanied by inactivation of ACC and increased activity of AMP-activated protein kinase (AMPK). This study was designed to determine the effect of exercise intensity on the enzyme kinetics of ACC, malonyl-CoA levels, and AMPK activity in skeletal muscle. Male Sprague-Dawley rats were killed (pentobarbital sodium anesthesia) at rest or after 5 min of exercise (10, 20, 30, or 40 m/min at 5% grade). The fast-twitch red and white regions of the quadriceps muscle were excised and frozen in liquid nitrogen. A progressive decrease in red quadriceps ACC maximal velocity (from 28.6 +/- 1.5 to 14.3 +/- 0.7 nmol . g-1 . min-1, P < 0.05), an increase in activation constant for citrate, and a decrease in malonyl-CoA (from 1.9 +/- 0.2 to 0.9 +/- 0.1 nmol/g, P < 0.05) were seen with the increase in exercise intensity from rest to 40 m/min. AMPK activity increased more than twofold. White quadriceps ACC activity decreased only during intense exercise. We conclude that the extent of ACC inactivation during short-term exercise is dependent on exercise intensity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9338417     DOI: 10.1152/jappl.1997.83.4.1104

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  34 in total

1.  How to avoid running on empty.

Authors:  M J Rennie
Journal:  J Physiol       Date:  2000-10-01       Impact factor: 5.182

2.  Malonyl coenzyme A and the regulation of functional carnitine palmitoyltransferase-1 activity and fat oxidation in human skeletal muscle.

Authors:  Blake B Rasmussen; Ulf C Holmbäck; Elena Volpi; Beatrice Morio-Liondore; Douglas Paddon-Jones; Robert R Wolfe
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

3.  AMP-activated protein kinase: an ultrasensitive system for monitoring cellular energy charge.

Authors:  D G Hardie; I P Salt; S A Hawley; S P Davies
Journal:  Biochem J       Date:  1999-03-15       Impact factor: 3.857

Review 4.  The molecular bases of training adaptation.

Authors:  Vernon G Coffey; John A Hawley
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 5.  Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms.

Authors:  Jessica M Scott; Aarif Khakoo; John R Mackey; Mark J Haykowsky; Pamela S Douglas; Lee W Jones
Journal:  Circulation       Date:  2011-08-02       Impact factor: 29.690

6.  Resistance exercise increases AMPK activity and reduces 4E-BP1 phosphorylation and protein synthesis in human skeletal muscle.

Authors:  Hans C Dreyer; Satoshi Fujita; Jerson G Cadenas; David L Chinkes; Elena Volpi; Blake B Rasmussen
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

7.  BRCA1 is a novel regulator of metabolic function in skeletal muscle.

Authors:  Kathryn C Jackson; Eva-Karin Gidlund; Jessica Norrbom; Ana P Valencia; David M Thomson; Rosemary A Schuh; P Darrell Neufer; Espen E Spangenburg
Journal:  J Lipid Res       Date:  2014-02-24       Impact factor: 5.922

Review 8.  Insulin resistance with aging: effects of diet and exercise.

Authors:  A S Ryan
Journal:  Sports Med       Date:  2000-11       Impact factor: 11.136

9.  Contractions but not AICAR increase FABPpm content in rat muscle sarcolemma.

Authors:  Jacob Jeppesen; Peter Albers; Joost J Luiken; Jan F C Glatz; Bente Kiens
Journal:  Mol Cell Biochem       Date:  2009-01-14       Impact factor: 3.396

10.  A chronic increase in physical activity inhibits fed-state mTOR/S6K1 signaling and reduces IRS-1 serine phosphorylation in rat skeletal muscle.

Authors:  Erin L Glynn; Heidi L Lujan; Victoria J Kramer; Micah J Drummond; Stephen E DiCarlo; Blake B Rasmussen
Journal:  Appl Physiol Nutr Metab       Date:  2008-02       Impact factor: 2.665

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.